| 000 | 01619 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514004725.0 | ||
| 264 | 0 | _c20011101 | |
| 008 | 200111s 0 0 eng d | ||
| 022 | _a1058-4838 | ||
| 024 | 7 |
_a10.1086/322660 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDionisio, D | |
| 245 | 0 | 0 |
_aExtent of human immunodeficiency virus type 1 drug resistance as a predictor of virological failure after genotype-guided treatment switch. _h[electronic resource] |
| 260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cSep 2001 |
||
| 300 |
_a706-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xmethods |
| 650 | 0 | 4 |
_aDrug Resistance, Microbial _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHIV-1 _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Failure |
| 700 | 1 | _aVivarelli, A | |
| 700 | 1 | _aZazzi, M | |
| 700 | 1 | _aEsperti, F | |
| 700 | 1 | _aUberti, M | |
| 700 | 1 | _aPolidori, M | |
| 773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 33 _gno. 5 _gp. 706-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/322660 _zAvailable from publisher's website |
| 999 |
_c11413190 _d11413190 |
||